• 1
    Chen MS Jr. Cancer health disparities among Asian Americans: what we do and what we need to do. Cancer. 2005;104(suppl 12):28952902.
  • 2
    A Brown Paper: The Health of South Asians in the U.S., 1st ed. Berkeley, CA: South Asian Public Health Association; 2002.
  • 3
    U.S. Census Bureau. We the people: Asians in the United States. Census 2000 Special Report; 2000.
  • 4
    Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69e171.
  • 5
    Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:12331241.
  • 6
    Klatsky AL, Tekawa IS, Armstrong MA. Cardiovascular risk factors among Asian Americans. Public Health Rep. 1996;111(suppl 2):6264.
  • 7
    Kim MT, Juon HS, Hill MN, et al. Cardiovascular disease risk factors in Korean American elderly. West J Nurs Res. 2001;23:269282.
  • 8
    Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the Asian adult population: United States, 2004–2006. Adv Data. 2008;394:122.
  • 9
    Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2005. Vital Health Stat 10. 2006;232:1153.
  • 10
    Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25e146.
  • 11
    Enas EA, Garg A, Davidson MA, et al. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J. 1996;48:343353.
  • 12
    Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:6975.
  • 13
    Katsuya T, Ishikawa K, Sugimoto K, et al. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res. 2003;26:521525.
  • 14
    Lee YW, Oh VM, Garcia E, et al. Haplotypes of the beta2-adrenergic receptor gene are associated with essential hypertension in a Singaporean Chinese population. J Hypertens. 2004;22:21112116.
  • 15
    Sagnella GA, Rothwell MJ, Onipinla AK, et al. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J Hypertens. 1999;17:657664.
  • 16
    Wong CC, Mouanoutoua V, Chen MJ, et al. Adherence with hypertension care among Hmong Americans. J Community Health Nurs. 2005;22:143156.
  • 17
    Smith SC Jr, Clark LT, Cooper RS, et al. Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation. 2005;111:e134e139.
  • 18
    Lau DS, Lee G, Wong CC, et al. Characterization of systemic hypertension in the San Francisco Chinese community. Am J Cardiol. 2005;96:570573.
  • 19
    Lloyd-Jones DM, Sutton-Tyrrell K, Patel AS, et al. Ethnic variation in hypertension among premenopausal and perimenopausal women: study of women’s health across the nation. Hypertension. 2005;46:689695.
  • 20
    Viera AJ, Kshirsagar AV, Hinderliter AL. Lifestyle modifications to lower or control high blood pressure: is advice associated with action? The behavioral risk factor surveillance survey. J Clin Hypertens (Greenwich). 2008;10:105111.
  • 21
    Moser M, Franklin SS. Hypertension management: results of a new national survey for the hypertension education foundation: Harris interactive. J Clin Hypertens (Greenwich). 2007;9:316323.
  • 22
    Zhou HH, Koshakji RP, Silberstein DJ, et al. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med. 1989;320:565570.
  • 23
    Zhou HH, Adedoyin A, Wilkinson GR. Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther. 1990;48:1017.
  • 24
    Ranade K, Jorgenson E, Sheu WH, et al. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet. 2002;70:935942.
  • 25
    Wilk JB, Myers RH, Pankow JS, et al. Adrenergic receptor polymorphisms associated with resting heart rate: the HyperGEN Study. Ann Hum Genet. 2006;70(Pt 5):566573.
  • 26
    Biolo A, Clausell N, Santos KG, et al. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy. Am J Cardiol. 2008;102:726732.
  • 27
    Mahesh Kumar KN, Ramu P, Rajan S, et al. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population. J Cardiovasc Pharmacol. 2008;52:459466.
  • 28
    Brand E, Chatelain N, Mulatero P, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 1998;32:198204.
  • 29
    Matsubara M, Kikuya M, Ohkubo T, et al. Aldosterone synthase gene (CYP11B2) C-334T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: the Ohasama Study. J Hypertens. 2001;19:21792184.
  • 30
    Tsujita Y, Iwai N, Katsuya T, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the suita study. Hypertens Res. 2001;24:105109.
  • 31
    Tamaki S, Iwai N, Tsujita Y, et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension. 1999;33(1 Pt 2):266270.
  • 32
    Saruta T, Kageyama S, Ogihara T, et al. Efficacy and safety of the selective aldosterone blocker eplerenone in Japanese patients with hypertension: a randomized, double-blind, placebo-controlled, dose-ranging study. J Clin Hypertens (Greenwich). 2004;6:175183; quiz 184–185.
  • 33
    Tomlinson B, Woo J, Critchley JA, et al. Isradipine treatment for hypertension in general practice in Hong Kong. Chin Med J (Engl). 1992;105:446450.
  • 34
    Stensvold I, Tverdal A, Solvoll K, et al. Tea consumption: relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med. 1992;21:546553.
  • 35
    Wakabayashi K, Kono S, Shinchi K, et al. Habitual coffee consumption and blood pressure: a study of self-defense officials in Japan. Eur J Epidemiol. 1998;14:669673.
  • 36
    Yokogoshi H, Kato Y, Sagesaka YM, et al. Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats. Biosci Biotechnol Biochem. 1995;59:615618.
  • 37
    Yokogoshi H, Kobayashi M. Hypotensive effect of gamma-glutamylmethylamide in spontaneously hypertensive rats. Life Sci. 1998;62:10651068.
  • 38
    Abe Y, Umemura S, Sugimoto K, et al. Effect of green tea rich in gamma-aminobutyric acid on blood pressure of Dahl salt-sensitive rats. Am J Hypertens. 1995;8:7479.
  • 39
    Bingham SA, Vorster H, Jerling JC, et al. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr. 1997;78:4155.
  • 40
    Hodgson JM, Puddey IB, Burke V, et al. Effects on blood pressure of drinking green and black tea. J Hypertens. 1999;17:457463.
  • 41
    Yang YC, Lu FH, Wu JS, et al. The protective effect of habitual tea consumption on hypertension. Arch Intern Med. 2004;164:15341540.
  • 42
    Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol. 1995;40:141144.
  • 43
    Woo KS, Norris RM, Nicholls G. Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol. 1995;75:967968.
  • 44
    Ding PY, Hu OY, Pool PE, et al. Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? J Hum Hypertens. 2000;14:163170.
  • 45
    Sebastian JL, McKinney WP, Kaufman J, et al. Angiotensin-converting enzyme inhibitors and cough. Prevalence in an outpatient medical clinic population. Chest. 1991;99:3639.
  • 46
    Simon SR, Black HR, Moser M, et al. Cough and ACE inhibitors. Arch Intern Med. 1992;152:16981700.